Rebecca Fahrig is an innovator with more than two decades of academic and professional experience in pioneering new technology, developing new products and shaping their definition. Currently Rebecca serves as General Manager of Business Line Endovascular Robotics (EVR), and Head of Innovation for Business Area Advanced Therapies at Siemens Healthineers. At Siemens Healthineers Advanced Therapies Innovation she is spearheading digitalization initiatives aimed at revolutionizing interventional labs into future ‘context aware’ operating rooms. Her technical expertise lies in designing, characterizing and implementing cutting-edge x-ray imaging systems and AI image analytics for both diagnostic and image- guided procedures. At Siemens Healthineers Advanced Therapies EVR she is driving the vision of combined endovascular robotics, image guidance, and dedicated devices. The purpose-built next-generation robotic platform will significantly impact how neurovascular procedures are performed in the future. Rebecca holds a Master’s degree in Medical Biophysics from the University of Toronto, and a Phd from Western University in London, Ontario, Canada. Prior to her time at Siemens Healthineers, Dr. Fahrig was a professor at Stanford University running a research program in the Department of Radiology for 16 years. During her academic career, she played a pivotal role in the invention and introduction of conebeam CT to interventional suites and has continuously enhanced that technology through software and hardware innovations. Rebecca possesses extensive expertise across various image modalities including ultrasound, x-ray, CT, conebeam CT and MRI. Dr. Fahrig is a Fellow of SPIE, AAPM and AIMBE and an Honorary Professor of the Friedrich-Alexander University of Erlangen-Nuremberg. She is an elected member of the Board of Directors of SPIE (The Society of Photo-optical Instrumentation Engineers), and sits on the Scientific Advisory Board of IHU Strasbourg, and the Board of Directors of MassMEDIC.